Literature DB >> 23200665

A historical perspective of aromatase inhibitors for ovulation induction.

Robert F Casper1, Mohamed F M Mitwally.   

Abstract

The concept of using aromatase inhibitors in place of clomiphene citrate (CC) for ovulation induction was introduced >10 years ago; a brief history of its development is presented. Its worldwide usage for ovulation induction, including as an adjunct for intrauterine insemination and in vitro fertilization has occurred despite the absence of definitive data of superiority to CC. The results of two ongoing potentially definitive multicenter trials of efficacy and safety of letrozole compared with CC are eagerly awaited.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23200665     DOI： 10.1016/j.fertnstert.2012.10.008

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  16 in total

Review 1.  Clinical review: The use of aromatase inhibitors for ovulation induction and superovulation.

Authors:  Mary Ellen Pavone; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2013-04-12       Impact factor: 5.958

2.  Perinatal outcomes and congenital anomalies associated with letrozole and natural cycles in single fresh cleaved embryo transfers: A single-center, 10-year cohort study.

Authors:  Kazumi Takeshima; Kenji Ezoe; Nami Kawasaki; Hiroko Hayashi; Tomoko Kuroda; Keiichi Kato
Journal:  F S Rep       Date:  2022-03-06

3.  Fertility management in the PCOS population: results of a web-based survey at IVF-worldwide.com.

Authors:  Paul R Brezina; Virginia Mensah; Adam Balen; Milton Leong; Ariel Weissman; Yulian Zhao; Zeev Shoham
Journal:  J Assist Reprod Genet       Date:  2013-07-30       Impact factor: 3.412

4.  Effects of letrozole or tamoxifen coadministered with a standard stimulation protocol on fertility preservation among breast cancer patients.

Authors:  Foad Azem; Yoni Cohen; Yael Shulman; Benny Almog; Yael Kalma; Yuval Fouks
Journal:  J Assist Reprod Genet       Date:  2021-01-07       Impact factor: 3.412

5.  Factors associated with nonresponse to ovulation induction using letrozole among women with World Health Organization group II anovulation.

Authors:  Thilina Sanjeewa Palihawadana; Prasantha Sudehana Wijesinghe; Harshalal Rukka Seneviratne
Journal:  J Hum Reprod Sci       Date:  2015 Apr-Jun

6.  Congenital malformations among babies born following letrozole or clomiphene for infertility treatment.

Authors:  Sunita Sharma; Sanghamitra Ghosh; Soma Singh; Astha Chakravarty; Ashalatha Ganesh; Shweta Rajani; B N Chakravarty
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

Review 7.  Letrozole for Female Infertility.

Authors:  Ai-Min Yang; Na Cui; Yi-Fei Sun; Gui-Min Hao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-16       Impact factor: 5.555

Review 8.  Current evidence supporting "letrozole" for ovulation induction.

Authors:  Sujata Kar
Journal:  J Hum Reprod Sci       Date:  2013-04

Review 9.  Optimal management of subfertility in polycystic ovary syndrome.

Authors:  Joshua J Berger; G Wright Bates
Journal:  Int J Womens Health       Date:  2014-06-13

10.  Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study.

Authors:  D T Papadimitriou; E Dermitzaki; M Papagianni; G Papaioannou; V Papaevangelou; A Papadimitriou
Journal:  J Endocrinol Invest       Date:  2015-10-27       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.